APA (7th ed.) Citation

JMJ, W., B, N., C, W., A, L., A, A., & T, C. (2025). Low-risk febrile neutropenia: Does combined chemotherapy/immune checkpoint inhibitor necessitate a change in approach? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 33(2), 112. https://doi.org/10.1007/s00520-025-09168-4

Chicago Style (17th ed.) Citation

JMJ, Weaver, Nagy B, Wilson C, Lewis A, Armstrong A, and Cooksley T. "Low-risk Febrile Neutropenia: Does Combined Chemotherapy/immune Checkpoint Inhibitor Necessitate a Change in Approach?" Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 33, no. 2 (2025): 112. https://doi.org/10.1007/s00520-025-09168-4.

MLA (9th ed.) Citation

JMJ, Weaver, et al. "Low-risk Febrile Neutropenia: Does Combined Chemotherapy/immune Checkpoint Inhibitor Necessitate a Change in Approach?" Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 33, no. 2, 2025, p. 112, https://doi.org/10.1007/s00520-025-09168-4.